Key points are not available for this paper at this time.
Dendritic cells (DCs) play a pivotal role in the tumor microenvironment, which is known to affect disease progression in many human malignancies. Infiltration by mature, active DCs into the tumors confers an increase in immune activation and recruitment of disease-fighting immune effector cells and pathways. DCs are the preferential target of infiltrating T cells. However, tumor cells have means of suppressing DC function or of altering the tumor microenvironment in such a way that immune-suppressive DCs are recruited. Advances in understanding these changes have led to promising developments in cancer-therapeutic strategies targeting tumor-infiltrating DCs to subdue their immunosuppressive functions and enhance their immune-stimulatory capacity.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jo Marie Tran Janco
Purushottam Lamichhane
Lavakumar Karyampudi
The Journal of Immunology
Mayo Clinic
Mayo Clinic in Arizona
Mayo Clinic in Florida
Building similarity graph...
Analyzing shared references across papers
Loading...
Janco et al. (Sat,) studied this question.
www.synapsesocial.com/papers/6a0cb8e3660334d4fdeb2031 — DOI: https://doi.org/10.4049/jimmunol.1403134